Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Poly Medicure Limited (NSE: POLYMED), ISIN INE205C01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
POLYMED last traded at ₹1726.60 (+1.62%), with a 52-week range of ₹1184.00 to ₹2093.95 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 62.42%, FIIs 5.57%, DIIs 16.08%, mutual funds 9.61%.
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.